July 31, 2026 · Form 4 insider transaction
Hensley Mark Earl bought 11,769 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of common stock.